Search clinical trials for: exemestane (Aromasin)

Total 457 results

Pfizer

Terminated

Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

Breast Neoplasms

United States, Canada, Netherlands, Brazil, Belgium, United Kingdom, Argentina, Italy, Sweden
Fudan University

Unknown

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer (LEANEX)

Breast Cancer

China
Novosibirsk City Hospital #2
Siberian Branch of the Russian Academy of Medical Sciences

Completed

Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures 2

Chronic Obstructive Pulmonary Disease

Russian Federation
University of Washington
National Cancer Institute (NCI)

Completed

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Neoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)

France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
Brigham and Women's Hospital
Johns Hopkins University; National Institute on Aging (NIA); Rutgers University

Active, not recruiting

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole

Breast Cancer

United States
University of Washington
National Cancer Institute (NCI)

Completed

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
Institute of Cancer Research, United Kingdom

Unknown

Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer

Breast Cancer

United States
Shanghai Jiao Tong University School of Medicine

Completed

Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients (SEAT)

Breast Cancer

China
Novartis Pharmaceuticals

Completed

Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (EVEREXES)

Post Menopausal Breast Cancer

Taiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Cancer and Leukemia Group B

Completed

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Breast Cancer

United States
Xichun Hu

Completed

Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Complexo Hospitalario Universitario de A Coruña

Completed

Acceptance of Different Thickeners in Dysphagia

Dysphagia | Dysphagia, Oropharyngeal

Spain
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Determining Total Aromatic Amino Acid Requirements in Pregnant Women

Pregnancy Related

Canada
Cancer Institute and Hospital, Chinese Academy...

Unknown

Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients (FRIEND)

Breast Cancer

China
Novosibirsk City Hospital #2
Siberian Branch of the Russian Academy of Medical Sciences

Completed

Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures

Chronic Obstructive Pulmonary Disease

Russian Federation
Boehringer Ingelheim

Completed

BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors

Neoplasms

Italy, Belgium
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)

Withdrawn

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Washington University School of Medicine
Genomic Health®, Inc.

Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Breast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the Breast

United States
Dana-Farber Cancer Institute
Pfizer

Completed

Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer

Breast Cancer

United States
Guangdong Provincial People's Hospital

Not yet recruiting

Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer

Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer

Breast Cancer

China
Second Affiliated Hospital of Soochow University

Recruiting

A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC

Breast Neoplasms

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

Breast Cancer

United States
IRCCS Azienda Ospedaliera Universitaria San Martino...
Clinical Research Technology S.r.l.

Active, not recruiting

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer (GIM10-CONSENT)

Breast Cancer

Italy
ETOP IBCSG Partners Foundation
National Cancer Institute (NCI); Cancer and Leukemia Group B; Breast Cancer Trials...

Completed

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 (Co-SOFT)

Breast Cancer | Fatigue | Sleep Disorders

United States, Canada
Pfizer

Terminated

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

Breast Neoplasms

United States, Canada
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer

Breast Cancer

United States
Sun Yat-sen University

Active, not recruiting

Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer (MECCA)

Breast Cancer

China
Institut Català d'Oncologia

Unknown

Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer

Breast Cancer

Spain
HaEmek Medical Center, Israel

Completed

Treatment of Acute Tracheitis and Laryngitis With Essential Oils of Aromatic Plants

Viral Laryngitis | Viral Tracheitis

Israel
Peking University Cancer Hospital & Institute

Recruiting

Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Breast Neoplasm Female

China
National Taiwan University Hospital
Merck Sharp & Dohme LLC

Terminated

Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer (PEER)

Premenopausal Breast Cancer

Taiwan
Amsterdam UMC, location VUmc
Novartis; Borstkanker Onderzoek Groep

Unknown

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Metastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast

Netherlands
Xu fei
Sun Yat-sen University

Unknown

Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer (BETTER)

Breast Cancer

China
Andrea DeCensi
Herbert Irving Comprehensive Cancer Center; Breast Cancer Research Foundation; Istituto Europeo di Oncologia and other collaborators

Not yet recruiting

Babytam vs Babyexe in Post-menopausal Women at High Risk for Breast Cancer. (BabyTears)

Breast Cancer

Italy
Peking Union Medical College Hospital

Not yet recruiting

Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC (Pyrotinib)

Breast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
Pfizer

Active, not recruiting

Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

Breast Cancer

United States
Fuzhou General Hospital

Not yet recruiting

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Breast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor

China
NantCell, Inc.

Completed

QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Metastatic Cancer | Breast Tumors

United States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
Gruppo Italiano Mammella (GIM)

Unknown

Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

Breast Cancer

Italy
HaEmek Medical Center, Israel

Completed

Treatment of Acute Pharyngo-Tonsillitis With Essential Oils of Aromatic Plants

Viral Pharyngitis | Viral Tonsillitis

Israel
HaEmek Medical Center, Israel

Completed

Treatment of Acute Rhino-Sinusitis With Essential Oils of Aromatic Plants

Rhino-Sinusitis

Israel
Dharmais National Cancer Center Hospital

Completed

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Breast Cancer

Indonesia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer

Breast Neoplasms

China
UNICANCER
Pfizer

Active, not recruiting

PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection (PADA-1)

Metastatic Breast Cancer

France
Memorial Sloan Kettering Cancer Center
Pharmacia

Completed

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

Breast Cancer

United States
International Collaborative Cancer Group
European Organisation for Research and Treatment of Cancer - EORTC; UNICANCER

Unknown

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

Breast Cancer

France, Belgium, United Kingdom
Cancer Research Campaign Clinical Trials Centre

Completed

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Breast Cancer

United Kingdom

Search clinical trials for: exemestane (Aromasin)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations